Zoetis’ second quarter saw revenue and adjusted earnings surpass Wall Street expectations, but the market responded ...

Zoetis Inc. (NYSE:ZTS) today announced that it has agreed to sell $1.850 billion of senior notes, consisting of $850.0 ...

From supporting identification of certain cell characteristics to complementing clinical expertise with remote pathologist ...

Zoetis stock reversed Tuesday, sinking into the red, despite beating second-quarter expectations as Librela sales continued ...

The reality is that people and animals will always need medicine, treatments, and other products to live long and comfortable ...

Animal health company Zoetis (NYSE:ZTS) reported in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company ...

Finally, Zoetis is a dividend-paying stock, with a recent dividend yield of 1.3%. That may not seem like much, but the total annual payout, recently $1.93 per share, is up from $1.30 in 2022 and ...

Zoetis raised annual forecast and beat second-quarter estimates on Tuesday, driven by strong demand for its medicines and ...

Animal health firm Zoetis Inc. (NYSE:ZTS) on Tuesday reported a second-quarter 2025 adjusted earnings per share of $1.76, up ...

Zoetis Inc - Ordinary Shares - Class A News 7 Agriculture Stocks and ETFs to Buy Demand for food and agriculture products is high and growing fast. Here are 7 investments to buy now.

Zoetis Inc. closed 25.61% short of its 52-week high of $200.33, which the company reached on September 19th.

Shares of Zoetis Inc. ZTS rallied 1.09% to $147.38 Friday, on what proved to be an all-around dismal trading session for the ...